Deborah Autor, a deputy FDA commissioner, told the committee the agency currently has limited ability to conduct regular inspections of foreign suppliers or to block suspected drugs.
Committee members referred to a 2007 case when adulterated heparin reached the U.S. market from China.
Related Articles on Problems With Drug Shipments:
Senator Proposes System to Avert Drug Shortages, Improve Safety
Drug Shortages Spur Price Gouging, With Markups Averaging 650%
5 Updates on the Nationwide Drug Shortage
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
